QuickView for BRAF;jsessionid=2547D466A978ABBB1602416142B7EAE5;jsessionid=215045B3679A135B03BDF5EB620BEC53;jsessionid=B31CDC6997D0EC2012E540AD2670494C;jsessionid=C5F456891CB4A0839EB37C8A74CA24AF (gene)

1. Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models.
2. Computational analysis of natural product B-Raf inhibitors.
3. Design, synthesis and characterisation of a novel type II B-RAF paradox breaker inhibitor.
4. A novel BRAF::PTPRN2 fusion in meningioma: a case report.
5. Recent advances in B-RAF inhibitors as anticancer agents.

There were no clinical trials for BRAF;jsessionid=2547D466A978ABBB1602416142B7EAE5;jsessionid=215045B3679A135B03BDF5EB620BEC53;jsessionid=B31CDC6997D0EC2012E540AD2670494C;jsessionid=C5F456891CB4A0839EB37C8A74CA24AF